van Roon-Mom WM - Search Results

1

In silico discovery and experimental validation of new protein-protein interactions.

van Haagen HH, 't Hoen PA, de Morrée A, van Roon-Mom WM, Peters DJ, Roos M, Mons B, van Ommen GJ, Schuemie MJ. van Haagen HH, et al. Proteomics. 2011 Mar;11(5):843-53. doi: 10.1002/pmic.201000398. Epub 2011 Jan 31. Proteomics. 2011. PMID: 21280221

2

Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease.

van Roon-Mom WM, Pepers BA, 't Hoen PA, Verwijmeren CA, den Dunnen JT, Dorsman JC, van Ommen GB. van Roon-Mom WM, et al. BMC Mol Biol. 2008 Oct 9;9:84. doi: 10.1186/1471-2199-9-84. BMC Mol Biol. 2008. PMID: 18844975 Free PMC article.

3

Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.

Aziz NA, Jurgens CK, Landwehrmeyer GB; EHDN Registry Study Group; van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA. Aziz NA, et al. Neurology. 2009 Oct 20;73(16):1280-5. doi: 10.1212/WNL.0b013e3181bd1121. Epub 2009 Sep 23. Neurology. 2009. PMID: 19776381

4

A 3 months mild functional test regime does not affect disease parameters in young mdx mice.

van Putten M, de Winter C, van Roon-Mom W, van Ommen GJ, 't Hoen PA, Aartsma-Rus A. van Putten M, et al. Neuromuscul Disord. 2010 Apr;20(4):273-80. doi: 10.1016/j.nmd.2010.02.004. Epub 2010 Mar 21. Neuromuscul Disord. 2010. PMID: 20307983

5

Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA.

Mastrokolias A, den Dunnen JT, van Ommen GB, 't Hoen PA, van Roon-Mom WM. Mastrokolias A, et al. BMC Genomics. 2012 Jan 18;13:28. doi: 10.1186/1471-2164-13-28. BMC Genomics. 2012. PMID: 22257641 Free PMC article.

6

Exploring the transcriptome of ciliated cells using in silico dissection of human tissues.

Ivliev AE, 't Hoen PA, van Roon-Mom WM, Peters DJ, Sergeeva MG. Ivliev AE, et al. PLoS One. 2012;7(4):e35618. doi: 10.1371/journal.pone.0035618. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558177 Free PMC article.

7

Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification.

Evers MM, Tran HD, Zalachoras I, Meijer OC, den Dunnen JT, van Ommen GJ, Aartsma-Rus A, van Roon-Mom WM. Evers MM, et al. Nucleic Acid Ther. 2014 Feb;24(1):4-12. doi: 10.1089/nat.2013.0452. Epub 2013 Dec 31. Nucleic Acid Ther. 2014. PMID: 24380395

8

Selection and characterization of llama single domain antibodies against N-terminal huntingtin.

Schut MH, Pepers BA, Klooster R, van der Maarel SM, El Khatabi M, Verrips T, den Dunnen JT, van Ommen GJ, van Roon-Mom WM. Schut MH, et al. Neurol Sci. 2015 Mar;36(3):429-34. doi: 10.1007/s10072-014-1971-6. Epub 2014 Oct 8. Neurol Sci. 2015. PMID: 25294428 Free PMC article.

9

Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.

Mastrokolias A, Ariyurek Y, Goeman JJ, van Duijn E, Roos RA, van der Mast RC, van Ommen GB, den Dunnen JT, 't Hoen PA, van Roon-Mom WM. Mastrokolias A, et al. Eur J Hum Genet. 2015 Oct;23(10):1349-56. doi: 10.1038/ejhg.2014.281. Epub 2015 Jan 28. Eur J Hum Genet. 2015. PMID: 25626709 Free PMC article.

10

Making (anti-) sense out of huntingtin levels in Huntington disease.

Evers MM, Schut MH, Pepers BA, Atalar M, van Belzen MJ, Faull RL, Roos RA, van Roon-Mom WM. Evers MM, et al. Mol Neurodegener. 2015 Apr 28;10:21. doi: 10.1186/s13024-015-0018-7. Mol Neurodegener. 2015. PMID: 25928884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters